Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation.

Ward KN, Hill JA, Hubacek P, de la Camara R, Crocchiolo R, Einsele H, Navarro D, Robin C, Cordonnier C, Ljungman P; 2017 European Conference on Infections in Leukaemia (ECIL).

Haematologica. 2019 Nov;104(11):2155-2163. doi: 10.3324/haematol.2019.223073. Epub 2019 Aug 29.

2.

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.

Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, Averbuch D, Cesaro S, de la Camara R, Baldomero H, Bader P, Basak G, Bonini C, Duarte R, Dufour C, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Kröger N, Mohty M, Gratwohl A; Infectious Diseases Working Party EBMT.

Bone Marrow Transplant. 2019 Aug 27. doi: 10.1038/s41409-019-0624-z. [Epub ahead of print]

PMID:
31455899
3.

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT.

Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, Ward KN, Cordonnier C, de la Camara R, Averbuch D, Knelange N, Socié G, Chevallier P, Blaise D, Yakoub-Agha I, Forcade E, Cornelissen J, Maertens J, Petersen E, Nguyen-Quoc S, Veelken H, Schaap N, Passweg J, Michallet M, Fegueux N, Deconinck E, Russell N, Basak G, Bader P, Montoto S, Kröger N, Cesaro S; Infectious Diseases Working Party EBMT.

Bone Marrow Transplant. 2019 Jul 30. doi: 10.1038/s41409-019-0627-9. [Epub ahead of print]

PMID:
31363166
4.

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, Hubacek P, Navarro D, Cordonnier C, Ward KN; 2017 European Conference on Infections in Leukaemia group.

Lancet Infect Dis. 2019 Aug;19(8):e260-e272. doi: 10.1016/S1473-3099(19)30107-0. Epub 2019 May 29. Review.

PMID:
31153807
5.

Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies.

Gudiol C, Aguilar-Guisado M, Azanza JR, Candel FJ, Cantón R, Carratalà J, Garcia-Vidal C, Jarque I, Lizasoain M, Gil-Bermejo JM, Ruiz-Camps I, Sánchez-Ortega I, Solano C, Suárez-Lledó M, Vázquez L, de la Cámara R.

Enferm Infecc Microbiol Clin. 2019 Mar 26. pii: S0213-005X(19)30130-2. doi: 10.1016/j.eimc.2019.01.013. [Epub ahead of print] English, Spanish.

PMID:
30926172
6.

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation.

Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502.

7.

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.

Santos N, Rodríguez-Romanos R, de la Cámara R, Brunet S, Nieto JB, Buño I, Martínez C, Jiménez-Velasco A, Vallejo C, González M, Solano C, Ferrá C, Sampol A, Pérez-Simón JA, López-Jiménez J, Díez JL, Gallardo D; GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH).

Ann Hematol. 2018 Nov;97(11):2217-2224. doi: 10.1007/s00277-018-3438-y. Epub 2018 Jul 17.

PMID:
30019128
8.

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.

Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Yanez San Segundo L, Pabst T, Özçelik T, Klyasova G, Donnini I, Wu D, Gülbas Z, Zuckerman T, Botelho de Sousa A, Beguin Y, Xhaard A, Bachy E, Ljungman P, de la Camara R, Rascon J, Ruiz Camps I, Vitek A, Patriarca F, Cudillo L, Vrhovac R, Shaw PJ, Wolfs T, O'Brien T, Avni B, Silling G, Al Sabty F, Graphakos S, Sankelo M, Sengeloev H, Pillai S, Matthes S, Melanthiou F, Iacobelli S, Styczynski J, Engelhard D, Cesaro S.

Clin Infect Dis. 2017 Nov 13;65(11):1819-1828. doi: 10.1093/cid/cix646.

9.

Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

Gallardo D, Bosch-Vizcaya A, Rodríguez-Romanos R, Santos N, Buño I, de la Cámara R, Brunet S, Jiménez-Velasco A, González M, Nieto JB, Martínez-Laperche C, Vallejo C, Ferrá C, Sampol A, López-Jiménez J, Pérez-Simón JA, Martínez C, Díez JL; GvHD/Immunotherapy Committee of the Spanish Hematopoietic Transplant Group.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2042-2047. doi: 10.1016/j.bbmt.2017.08.003. Epub 2017 Aug 4.

10.

[Consensus opinion on antifungal prophylaxis in haematologic patients: Results of the PROMIC project].

Vázquez López L, Villaescusa de la Rosa T, de la Cámara R, Espigado I, Grau Cerrato S, Jurado M, Rovira M, Salavert M, Serrano Simonneau D, Solano Vercet C, Ruiz Camps I.

Rev Esp Quimioter. 2017 Jun;30(3):213-223. Epub 2017 May 23. Spanish.

11.

Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication.

Arteche-López A, Kreutzman A, Alegre A, Sanz Martín P, Aguado B, González-Pardo M, Espiño M, Villar LM, García Belmonte D, de la Cámara R, Muñoz-Calleja C.

Bone Marrow Transplant. 2017 Jun;52(6):832-838. doi: 10.1038/bmt.2017.29. Epub 2017 Apr 3.

PMID:
28368375
12.

[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].

González-Romo F, Picazo JJ, García Rojas A, Labrador Horrillo M, Barrios V, Magro MC, Gil Gregorio P, de la Cámara R, Rodríguez A, Barberán J, Botía Martínez F, Linares Rufo M, Jimeno Sanz I, Portolés JM, Sanz Herrero F, Espinosa Arranz J, García-Sánchez V, Galindo Izquierdo M, Mascarós E.

Rev Esp Quimioter. 2017 Apr;30(2):142-168. Epub 2017 Feb 15. Spanish.

13.

IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.

Corrales I, Solano C, Amat P, Giménez E, de la Cámara R, Nieto J, López J, García-Noblejas A, Piñana JL, Navarro D.

J Med Virol. 2017 Apr;89(4):685-695. doi: 10.1002/jmv.24676. Epub 2016 Sep 14.

PMID:
27591738
14.

Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients.

Navarro D, Amat P, de la Cámara R, López J, Vázquez L, Serrano D, Nieto J, Rovira M, Piñana JL, Giménez E, Solano C.

Open Forum Infect Dis. 2016 May 18;3(2):ofw107. doi: 10.1093/ofid/ofw107. eCollection 2016 Apr.

15.

CMV in Hematopoietic Stem Cell Transplantation.

de la Cámara R.

Mediterr J Hematol Infect Dis. 2016 Jun 20;8(1):e2016031. doi: 10.4084/MJHID.2016.031. eCollection 2016. Review.

16.

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.

Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, Ljungman P; Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).

Haematologica. 2016 Jul;101(7):803-11. doi: 10.3324/haematol.2016.144428. Review.

17.

The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.

Noriega V, Martínez-Laperche C, Buces E, Pion M, Sánchez-Hernández N, Martín-Antonio B, Guillem V, Bosch-Vizcaya A, Bento L, González-Rivera M, Balsalobre P, Kwon M, Serrano D, Gayoso J, de la Cámara R, Brunet S, Rojas-Contreras R, Nieto JB, Martínez C, Gónzalez M, Espigado I, Vallejo JC, Sampol A, Jiménez-Velasco A, Urbano-Ispizua A, Solano C, Gallardo D, Díez-Martín JL, Buño I; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH).

PLoS One. 2015 Oct 16;10(10):e0140454. doi: 10.1371/journal.pone.0140454. eCollection 2015.

18.

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation.

Santos N, Rodríguez-Romanos R, Nieto JB, Buño I, Vallejo C, Jiménez-Velasco A, Brunet S, Buces E, López-Jiménez J, González M, Ferrá C, Sampol A, de la Cámara R, Martínez C, Gallardo D; GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH).

Bone Marrow Transplant. 2016 Jan;51(1):79-82. doi: 10.1038/bmt.2015.207. Epub 2015 Sep 14.

PMID:
26367234
19.

Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.

Solano C, de la Cámara R, Vázquez L, López J, Giménez E, Navarro D.

J Clin Microbiol. 2015 Aug;53(8):2741-4. doi: 10.1128/JCM.01057-15. Epub 2015 Jun 10.

20.

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.

Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D.

Transpl Infect Dis. 2015 Jun;17(3):361-70. doi: 10.1111/tid.12391. Epub 2015 Jun 1.

PMID:
25850900
21.

Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.

Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, López J, Garcia-Noblejas A, Navarro D.

J Med Virol. 2015 Sep;87(9):1601-7. doi: 10.1002/jmv.24198. Epub 2015 Mar 19.

PMID:
25802229
22.

A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation.

Fox ML, Barba P, Heras I, López-Parra M, González-Vicent M, de la Cámara R, Batlle M, Parody R, Vallejo C, Ruiz-Camps I, Vázquez L; Infectious and Non-Infectious Complications Subcommittee of the Spanish Haematopoietic Transplant Group (Grupo Español de Trasplante Hematopoyético; GETH).

Clin Microbiol Infect. 2015 Jan;21(1):e1-3. doi: 10.1016/j.cmi.2014.08.006. Epub 2014 Oct 13. No abstract available.

23.

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.

Parody R, Martino R, de la Cámara R, García-Noblejas A, Esquirol A, Garcia-Cadenas I, Villaescusa T, Caballero D, Rovira M, Fernandez-Avilés F, Marquez-Malaver FJ, Espigado I, Castilla-Llorente C, Heras I, Cabero MA, Cabrera JR, Barba P, Valcarcel D, Sánchez-Ortega I, Duarte RF, Serrano D, Carretero F, Vazquez L.

Bone Marrow Transplant. 2015 Feb;50(2):274-81. doi: 10.1038/bmt.2014.229. Epub 2014 Oct 27.

PMID:
25347007
24.

Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT.

Bosch-Vizcaya A, Rodriguez-Romanos R, Nieto JB, de la Cámara R, Brunet S, Vallejo C, Osca-Gelis G, Martínez-Laperche C, Buño I, Urbano-Ispizúa Á, González M, Jiménez-Velasco A, Gallardo D.

Bone Marrow Transplant. 2015 Feb;50(2):298-300. doi: 10.1038/bmt.2014.234. Epub 2014 Oct 20. No abstract available.

PMID:
25330223
25.

Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.

Corrales I, Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, Garcia-Noblejas A, Navarro D.

J Med Virol. 2015 Feb;87(2):248-55. doi: 10.1002/jmv.24050. Epub 2014 Aug 17.

PMID:
25132583
26.

Recommendations for vaccination against pneumococcus in kidney patients in Spain.

Portolés-Pérez J, Marques-Vidas M, Picazo JJ, González-Romo F, García-Rojas A, Pérez-Trallero E, Gil-Gregorio P, de la Cámara R, Morató ML, Rodríguez A, Barberán J, Domínguez-Hernández V, Linares-Rufo M, Jimeno-Sanz I, Sanz-Herrero F, Espinosa-Arranz J, García-Sánchez V, Galindo-Izquierdo M, Martínez-Castelao A.

Nefrologia. 2014;34(5):545-51. doi: 10.3265/Nefrologia.pre2014.May.12534. Epub 2014 Jun 8. English, Spanish.

27.

Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

Ljungman P, Brand R, Hoek J, de la Camara R, Cordonnier C, Einsele H, Styczynski J, Ward KN, Cesaro S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Clin Infect Dis. 2014 Aug 15;59(4):473-81. doi: 10.1093/cid/ciu364. Epub 2014 May 20.

PMID:
24850801
28.

An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.

Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D.

J Med Virol. 2014 May;86(5):806-11. doi: 10.1002/jmv.23742. Epub 2013 Sep 16.

PMID:
24105728
29.

[Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].

Picazo JJ, González-Romo F, García Rojas A, Peréz-Trallero E, Gil Gregorio P, de la Cámara R, Morató ML, Rodríguez A, Barberán J, Domínguez Hernández V, Linares Rufo M, Jimeno Sanz I, Portolés JM, Sanz Herrero F, Espinosa Arranz J, García-Sánchez V, Galindo Izquierdo M.

Rev Esp Quimioter. 2013 Sep;26(3):232-52. Spanish. No abstract available.

30.

A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.

Guillem V, Hernández-Boluda JC, Gallardo D, Buño I, Bosch A, Martínez-Laperche C, de la Cámara R, Brunet S, Martin C, Nieto JB, Martínez C, Pérez A, Montoro J, Garcia-Noblejas A, Solano C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH).

Am J Hematol. 2013 Oct;88(10):883-9. doi: 10.1002/ajh.23523. Epub 2013 Aug 1.

31.

A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT.

Martín-Antonio B, Suarez-Lledo M, Arroyes M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Gallardo D, Bosch A, Buño I, Martínez-Laperche C, Jiménez-Velasco A, de la Cámara R, Brunet S, Nieto JB, Urbano-Ispizua A.

Bone Marrow Transplant. 2013 Sep;48(9):1205-11. doi: 10.1038/bmt.2013.43. Epub 2013 Apr 1.

PMID:
23542224
32.

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.

Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P.

Transpl Infect Dis. 2013 Jun;15(3):219-32. doi: 10.1111/tid.12054. Epub 2013 Jan 31. Review.

PMID:
23363310
33.

[Consensus document on vaccination against influenza in health care workers].

Picazo JJ, Alonso LM, Arístegui J, Bayas JM, Sanz J, Del Amo P, Cobos JL, Rodríguez-Salazar J, Sánchez-Pastor M, de la Cámara R, Carratalá J, Cañada JL, González-Del Castillo J, Aldaz P, Pérez-Escanilla F, Barberán J, Rodríguez A, Vigil-Escribano D, Espinosa-Arranz J, Blanquer J, González-Romo F.

Rev Esp Quimioter. 2012 Sep;25(3):226-39. Spanish.

34.

Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.

Mellado E, De La Camara R, Buendía B, Rodriguez-Tudela JL, Cuenca-Estrella M.

Rev Iberoam Micol. 2013 Jan 3;30(1):64-8. doi: 10.1016/j.riam.2012.09.002. Epub 2012 Sep 15.

PMID:
22986228
35.

Inadequate references in recent article.

de la Cámara R, Jarque I, Grau S, Carreras E.

Am J Health Syst Pharm. 2012 Jun 1;69(11):917-22; author reply 922. doi: 10.2146/ajhp120091. No abstract available.

PMID:
22610019
36.

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.

Grau S, de la Cámara R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA.

BMC Infect Dis. 2012 Apr 3;12:83. doi: 10.1186/1471-2334-12-83.

37.

Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.

Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D.

J Med Virol. 2012 Feb;84(2):259-67. doi: 10.1002/jmv.22254.

PMID:
22170546
38.

Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.

Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Martín-Dávila P, de la Cámara R, Salavert M, de la Torre J, Cisneros JM; Spanish Network for Research in Infectious Diseases.

Clin Transplant. 2011 Nov-Dec;25(6):E629-38. doi: 10.1111/j.1399-0012.2011.01495.x. Epub 2011 Aug 21.

PMID:
22150886
39.

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.

Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain.

Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858.

PMID:
22024510
40.

Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.

Solano C, Benet I, Remigia MJ, de la Cámara R, Muñoz-Cobo B, Costa E, Clari MÁ, Bravo D, Amat P, Navarro D.

Transplantation. 2011 Aug 27;92(4):e17-20. doi: 10.1097/TP.0b013e318224f263. No abstract available.

PMID:
21814124
41.

Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recipients.

Solano C, Tormo N, de la Cámara R, Bartolo Nieto J, López J, Benet I, Muñoz-Cobo B, Costa E, Remigia MJ, Garcia-Noblejas A, Bravo D, Navarro D.

Clin Infect Dis. 2011 Aug 1;53(3):313-5; author reply 315-6. doi: 10.1093/cid/cir414. No abstract available.

PMID:
21765090
42.

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.

Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation; Infectious Complications Subcommittee, Spanish Group of Haematopoietic Stem-cell Transplantation.

Haematologica. 2011 Aug;96(8):1231-5. doi: 10.3324/haematol.2011.041913. Epub 2011 May 5.

43.

[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].

Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert M, de la Cámara R, Borges M, Cervera C, Garnacho J, Lassaleta Á, Lumbreras C, Sanz MÁ, Ramos JT, Torre-Cisneros J, Aguado JM, Cuenca-Estrella M; Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED).

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):435-54. doi: 10.1016/j.eimc.2011.01.010. Epub 2011 Apr 6. Spanish.

PMID:
21474210
44.

Update on fungemia in oncology and hematology.

Carreras E, Vázquez L, Rodríguez Tudela JL, Pahisa A, Azanza JR, Rovira M, de la Cámara R.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 4:42-7. doi: 10.1016/S0213-005X(11)70035-0. Review.

PMID:
21458719
45.

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab.

Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, Solano C, de la Cámara R, Rosell AI, Varela R, García MD, González-Barca E, López J, Pérez E, Ferrer S, Casado LF, Vázquez L, Villalón L, García-Marco JA.

Expert Rev Hematol. 2011 Feb;4(1):9-16. doi: 10.1586/ehm.10.77.

PMID:
21322774
46.

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.

Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1437-43. doi: 10.1038/bmt.2010.330. Epub 2011 Jan 17.

PMID:
21243030
47.

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection.

Muñoz-Cobo B, Solano C, Nieto J, de la Cámara R, Remigia MJ, Garcia-Noblejas A, López J, Benet I, Hernández-Boluda JC, Costa E, Bravo D, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1484-6. doi: 10.1038/bmt.2010.322. Epub 2011 Jan 10. No abstract available.

PMID:
21217790
48.

Treatment and timing in invasive mould disease.

Maertens J, Groll AH, Cordonnier C, de la Cámara R, Roilides E, Marchetti O.

J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i37-43. doi: 10.1093/jac/dkq440. Review.

PMID:
21177402
49.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K, Pigneux A, Cornely OA, Ullmann AJ, Bofarull RM, de la Cámara R, Weisser M, Liakopoulou E, Abecasis M, Heussel CP, Pineau M, Ljungman P, Einsele H; Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI) study group; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation.

Haematologica. 2010 Oct;95(10):1762-8. doi: 10.3324/haematol.2009.020073. Epub 2010 Jul 15.

50.

Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.

Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, Garcia-Noblejas A, Clari MA, Chilet M, López J, Hernández-Boluda JC, Remigia MJ, Navarro D.

J Med Virol. 2010 Jul;82(7):1208-15. doi: 10.1002/jmv.21799.

PMID:
20513086

Supplemental Content

Loading ...
Support Center